It has been established that acyltransferases preferentially incorporate MUFA into newly synthesized lipids than SFA [25,26]; hence, a chronically up-regulated SCD1 may be able supply the overactive lipid biosynthetic machinery of fast-replicating cancer cells with a great provision of ideal fatty acid substrates. The gene discussed is SCD; the disease is cancer.